MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 264 filers reported holding MYRIAD GENETICS INC in Q1 2019. The put-call ratio across all filers is 2.77 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $493,000 | +32.2% | 14,859 | +15.9% | 0.00% | 0.0% |
Q4 2018 | $373,000 | -24.3% | 12,825 | +19.6% | 0.00% | 0.0% |
Q3 2018 | $493,000 | +7.2% | 10,725 | -12.8% | 0.00% | 0.0% |
Q2 2018 | $460,000 | -5.7% | 12,304 | -25.4% | 0.00% | 0.0% |
Q1 2018 | $488,000 | -13.5% | 16,498 | +0.4% | 0.00% | 0.0% |
Q4 2017 | $564,000 | -8.4% | 16,438 | -3.5% | 0.00% | 0.0% |
Q3 2017 | $616,000 | -5.4% | 17,042 | -32.3% | 0.00% | 0.0% |
Q2 2017 | $651,000 | +12.4% | 25,175 | -16.6% | 0.00% | 0.0% |
Q1 2017 | $579,000 | – | 30,171 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SCOPIA CAPITAL MANAGEMENT LP | 6,459,139 | $278,776,000 | 5.53% |
Tieton Capital Management, LLC | 119,290 | $5,149,000 | 4.04% |
RPg Family Wealth Advisory, LLC | 97,202 | $4,195,238,000 | 3.85% |
RK Capital | 384,900 | $16,612,000 | 2.90% |
Contrarius Investment Management Ltd | 652,288 | $28,153,000 | 2.65% |
S&T BANK/PA | 331,885 | $14,324,000 | 2.22% |
Euclidean Technologies Management, LLC | 40,917 | $1,766,000 | 1.90% |
AIMZ Investment Advisors, LLC | 45,635 | $1,970,000 | 1.80% |
Taylor Frigon Capital Management LLC | 34,783 | $1,486,000 | 1.67% |
KILLEN GROUP INC | 366,305 | $15,810,000 | 1.63% |